Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier African Minerals Regulatory News (PREM)

Share Price Information for Premier African Minerals (PREM)

Share Price is delayed by 15 minutes
Get Live Data
0.023    0.002 (9.52%)
Bid:
0.022
Ask:
0.024
Spread: 0.002 (9.091%)
Market Cap: £9.04m
PREM Live PriceLast checked at - London Stock Exchange

Intraday Premier African Minerals Share Chart

Director's Loan

5 Jun 2018 07:00

RNS Number : 2671Q
Premier African Minerals Limited
05 June 2018
 

Premier African Minerals Limited / Ticker: PREM / Index: AIM / Sector: Mining

For immediate release

 

5 June 2018

 

Premier African Minerals Limited

Director's Loan

 

 

Premier African Minerals Limited ("Premier" or the "Company") announces that the Company has entered into a loan ("Loan") with a company owned by a Trust of which George Roach is a beneficiary, for a gross value of US$300,000.

 

Terms of the Loan

The Company entered into the loan on 4 June 2018. The Loan is non-interest bearing and has a maturity of 60 days and will provide additional general working capital while the Company looks to bring finality to the negotiations currently underway in respect of both Zulu Lithium Private Limited and RHA Tungsten Private Limited. The Company will repay the entire Loan, including all fees within five days following the maturity of the Loan. The Loan carries an implementation fee of US$15,000 (5%) and a redemption fee of US$15,000 (5%), collectively the fees ("Fees"). The terms and conditions of the Loan contains a negative pledge provision in respect of the Company relating to certain types of indebtedness and standard events of default. The Loan is not convertible, nor does it include share-based repayment or warrants.

 

The Company has agreed not to draw down against any equity or equity linked financing facilities, until such time as the Loan has been repaid. The Loan is secured against the Company's shareholding of 6,128,822 shares in ARC Minerals Limited ("Arc Shares") and the Company has agreed to underwrite any reasonable shortfall following the sale of the Arc shares, should this be necessary.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged the release of this announcement on behalf of the Company was Russel Swarts.

 

Enquiries:

Fuad Sillem

Premier African Minerals Limited

Tel: +44 (0)7734 922074

Michael Cornish / Roland Cornish

Beaumont Cornish Limited

(Nominated Adviser)

Tel: +44 (0) 20 7628 3396

Jerry Keen/Edward Mansfield

Shore Capital Stockbrokers Limited

Tel: +44 (0) 20 7408 4090

Jonathan Evans

Brandon Hill Capital Limited

Tel: +44 (0) 20 3463 5000

 

Notes to Editors:

Premier African Minerals Limited (AIM: PREM) is a multi-commodity mining and natural resource development company focused on Southern Africa with its RHA and Zulu projects in Zimbabwe.

 

The Company has a diverse portfolio of projects, which include tungsten, rare earth elements, lithium and tantalum in Zimbabwe, encompassing brownfield projects with near-term production potential to grass-roots exploration. In addition, the Company holds 5,010,333 shares in Circum Minerals Limited ("Circum"), the owners of the Danakil Potash Project in Ethiopia, which has the potential to be a world class asset. Premier also has an interest in Arc Minerals that has a number of mineral assets in Europe and Africa.

 

Forward Looking Statements:

Certain statements in this announcement are or may be deemed to be forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'' ''could'' "should" ''envisage'' ''estimate'' ''intend'' ''may'' ''plan'' ''will'' or the negative of those variations or comparable expressions including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth results of operations performance future capital and other expenditures (including the amount. nature and sources of funding thereof) competitive advantages business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors. Many factors could cause actual results to differ materially from the results discussed in the forward-looking statements including risks associated with vulnerability to general economic and business conditions competition environmental and other regulatory changes actions by governmental authorities the availability of capital markets reliance on key personnel uninsured and underinsured losses and other factors many of which are beyond the control of the Company. Although any forward-looking statements contained in this announcement are based upon what the Directors believe to be reasonable assumptions. The Company cannot assure investors that actual results will be consistent with such forward looking statements.

 

ENDS

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDMGGVMDKGRZZ
Date   Source Headline
19th May 20237:00 amRNSFunding and Appointment of Joint Broker
15th May 20237:00 amRNSFunding of Ongoing Zulu Plant Optimisation
5th May 20235:00 pmRNSCorporate Update
28th Apr 20237:00 amRNSDirector / PDMR shareholding
27th Apr 20231:00 pmRNSZulu Lithium Update
12th Apr 202312:30 pmRNSZulu Lithium Update
3rd Apr 202310:00 amRNSZulu Lithium Update
29th Mar 20232:00 pmRNSZulu Lithium Update
27th Feb 20237:00 amRNSZulu Assay Results
21st Feb 20231:00 pmRNSZulu Pilot Plant Update
30th Jan 20237:00 amRNSZulu Assay Results and Pilot Plant Update
9th Jan 20232:00 pmRNSResult of AGM
23rd Dec 20227:00 amRNSNotice of AGM
20th Dec 20228:00 amRNSZulu Assay Results and Pilot Plant Update
20th Oct 20227:00 amRNSZulu Assay Results and Pilot Plant Update
30th Sep 20227:00 amRNSHalf-year Report
7th Sep 20227:00 amRNSZulu Assay Results and Pilot Plant Update
26th Aug 20229:00 amRNSZulu Assay Results and Pilot Plant Update
15th Aug 20224:41 pmRNSSecond Price Monitoring Extn
15th Aug 20224:35 pmRNSPrice Monitoring Extension
3rd Aug 20227:00 amRNSZulu Lithium Project Pilot Plant Update
26th Jul 20227:00 amRNSZulu Assay Results and Pilot Plant Update
14th Jul 20227:00 amRNSZulu Assay Results Update
1st Jul 20227:00 amRNSZulu Assay Results Update
30th Jun 20222:00 pmRNSFinal Results
24th Jun 20227:00 amRNSZulu Lithium Project Pilot Plant
13th Jun 20222:05 pmRNSSecond Price Monitoring Extn
13th Jun 20222:00 pmRNSPrice Monitoring Extension
13th Jun 20227:00 amRNSInterim update Zulu Lithium Project
31st May 20227:00 amRNSGrant of Options
4th May 20229:06 amRNSSecond Price Monitoring Extn
4th May 20229:00 amRNSPrice Monitoring Extension
27th Apr 20228:00 amRNSResignation of Director
25th Apr 20227:00 amRNSJoint Venture Agreement
14th Apr 20227:00 amRNSAppointment of Director
1st Apr 20224:05 pmRNSHolding(s) in Company
29th Mar 20221:00 pmRNSCompletion of Zulu Lithium DFS Funding
25th Mar 20222:06 pmRNSSecond Price Monitoring Extn
25th Mar 20222:00 pmRNSPrice Monitoring Extension
11th Mar 20229:00 amRNSZulu Lithium DFS Funding Deposit
9th Mar 20229:05 amRNSSecond Price Monitoring Extn
9th Mar 20229:00 amRNSPrice Monitoring Extension
8th Mar 20225:01 pmRNSZulu Lithium DFS Funding
22nd Feb 20229:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSZulu Update
16th Feb 202211:05 amRNSSecond Price Monitoring Extn
16th Feb 202211:00 amRNSPrice Monitoring Extension
16th Feb 20229:05 amRNSSecond Price Monitoring Extn
16th Feb 20229:00 amRNSPrice Monitoring Extension
15th Feb 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.